IMS Launches IMS Knowledge Link, Offering Instant Access to Global Pharmaceutical Market Intelligence
Web-Based Tool Sources Data from Three IMS Services for Comprehensive Insights on Sales, R&D, Pharma Company Profiles
FAIRFIELD, CT, December 2, 2002 – IMS Health (NYSE: RX) today announced the launch of IMS Knowledge Link, a unique Web-based system that offers instant access to integrated global pharmaceutical market intelligence from three leading IMS services -- IMS World Review, IMS Company Profiles and IMS Lifecycle R&D Focus -- to provide in-depth data and analysis of sales results, R&D activities and pharma company facts. IMS is the world’s leading provider of information solutions to the pharmaceutical and healthcare industries.
“IMS Knowledge Link is a powerful tool that delivers a wealth of insights and information to clients in user-friendly formats,” said IMS Marketing Manager Stephanie Earle. “Starting with one of four topics – Companies, Products, Therapies and Countries – you can find the facts you need on sales data and trends for hundreds of products, track the R&D progress of more than 6,000 drugs in active development, or take a closer look at the strategy, product portfolios and financial results of leading pharmaceutical companies. And because IMS Knowledge Link is a flexible, multi-level service, you can get a quick overview or drill deep into the information. The choice is yours.”
IMS Knowledge Link provides both in-depth and top-line information for users at every level, from product managers and analysts to senior pharmaceutical company executives. Features include:
- Sales data of drugs in more than 300 therapy areas, marketed by 126 companies in 23 countries
- Evaluations of the progress of products in the industry’s R&D pipelines, from pre-clinical phases to launch; and
- Profiles of 85 major pharmaceutical companies, including senior management interviews, mergers and acquisitions assessments, and forecasts from leading experts on the industry.
Users can conduct combination searches and link relevant insights in pre-formatted, Web-based reports. Each report offers direct access to the individual IMS World Review, IMS Company Profiles and IMS Lifecycle R&D Focus services for deeper insights. Patent data and market forecasts will soon be added to IMS Knowledge Link’s rich information offering. Click here to take a tour of IMS Knowledge Link.
For more information, contact Paul Jenner, director, IMS Communications and Marketing Services, by phone (+44 20 7393 5828) or e-mail (firstname.lastname@example.org).
Operating in more than 100 countries, IMS is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.3 billion in 2001 revenue and nearly 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients’ day-to-day operations, including marketing effectiveness solutions for prescription and over-the-counter pharmaceutical products; sales optimization solutions to increase pharmaceutical sales force productivity; and consulting and customized services that turn information into actionable insights.
December 2, 2002